Helius Stock Valuation

HSDT -  USA Stock  

USD 14.50  1.25  9.43%

What would the acquisition value of Helius Medical Techn be today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Helius Medical, is its stock price multiplied by the total number of shares outstanding, calculating Helius Medical's enterprise value requires a different approach. It uses Helius Medical's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Helius Medical Enterprise Value is comparatively stable at the moment as compared to the past year. Helius Medical reported Enterprise Value of 17.03 Million in 2020. Tangible Asset Value is likely to gain to about 7.2 M in 2021, whereas Free Cash Flow is likely to drop (12.7 M) in 2021.
Helius Medical Techn retains a regular Real Value of $16.71 per share. The prevalent price of the firm is $14.5. At this time, the firm appears to be undervalued. Our model calculates the value of Helius Medical Techn from evaluating the firm fundamentals such as Shares Owned by Insiders of 14.60 %, return on equity of (208.02) %, and Return On Asset of (105.08) % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage acquiring undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together.

Helius Valuation 

 
Refresh
Helius Medical Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Helius Medical's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
14.50
25th of October 2021
Share
Please note that Helius Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Helius Medical Techn is based on 3 months time horizon. Increasing Helius Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Helius Medical Technologies is useful when determining the fair value of the Helius stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Helius Medical. Since Helius Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Helius Stock. However, Helius Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
16.71
Real Value
19.74
Upside
Estimating the potential upside or downside of Helius Medical Technologies helps investors to forecast how Helius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Helius Medical more accurately as focusing exclusively on Helius Medical's fundamentals will not take into account other important factors:
Earnings
Estimates (2)
LowProjected EPSHigh
-7.64-7.6-7.55
Details
Hype
Prediction
LowEstimated ValueHigh
11.4714.5017.53
Details
Naive
Forecast
LowNext ValueHigh
11.3014.3317.36
Details
2 Analysts
Consensus
LowTarget PriceHigh
20.0025.7531.50
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Helius Medical's intrinsic value based on its ongoing forecasts of Helius Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Helius Medical's closest peers. When choosing an evaluation method for Helius Medical Techn, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Helius Valuation Drivers Correlation

Many accounts on the financial statements of Helius Medical Techn are highly interrelated and sometimes correlated. Consequently, when conducting Helius's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Helius
Click cells to compare fundamentals

Helius Valuation Trend

Knowing Helius Medical's actual value is paramount for traders to make sound investment determinations. Helius Medical's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Helius Medical's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Helius Medical's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Helius Market Cap

Helius Medical Technologies is rated below average in market capitalization category among related companies. Market capitalization of Medical Devices industry is currently estimated at about 96.92 Billion. Helius Medical adds roughly 30.84 Million in market capitalization claiming only tiny portion of all equities under Medical Devices industry.
Capitalization  Workforce  Revenue  Valuation  Total debt

Helius Medical Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Helius Medical's current stock value. Our valuation model uses many indicators to compare Helius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Helius Medical competition to find correlations between indicators driving Helius Medical's intrinsic value. More Info.
Helius Medical Technologies is one of the top stocks in price to sales category among related companies. It is rated below average in beta category among related companies totaling about  0.01  of Beta per Price to Sales. The ratio of Price to Sales to Beta for Helius Medical Technologies is roughly  76.98 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Helius Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Helius Medical's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Helius Medical's earnings, one of the primary drivers of an investment's value.

About Helius Medical Valuation

The equity valuation mechanism determines the current worth of Helius Medical Technologies on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Helius Medical Technologies. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Helius Medical Techn based exclusively on its fundamental and basic technical indicators. By analyzing Helius Medical's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Helius Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Helius Medical. We calculate exposure to Helius Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Helius Medical's related companies.
Last ReportedProjected for 2021
Gross Profit273 K340.3 K
Profit Margin(21.38) (23.07) 
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.

Helius Medical Quarterly Enterprise Value

28.05 MillionShare

Helius Medical Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Helius Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio3.58
Revenue Growth-46.60%
Enterprise Value To Ebitda-1.66
Enterprise Value To Revenue55.51

Helius Medical Current Valuation Indicators

Valuation refers to the process of determining the present value of Helius Medical Technologies and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Helius we look at many different elements of the entity such as Helius's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Helius Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Helius Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Helius Medical's worth.
Please check Risk vs Return Analysis. Note that the Helius Medical Techn information on this page should be used as a complementary analysis to other Helius Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Helius Stock analysis

When running Helius Medical Techn price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Is Helius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Helius Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.